Another Week, Another Venture Deal in N.C.

Venture capital may not be pouring down in North Carolina, but the steady showers have moved from April well into May.

The state continued its string of at least one deal per week last week, as Wilmington medical device maker TranS1 landed $12 million in its second round.

The deal brings the North Carolina total for venture capital for the year to $117 million in 18 deals. By early May a year ago, the state had seen 24 deals for almost $120 million.

Here is LTW’s exclusive list of North Carolina venture deals, ranked according to the size of the investment:

Company; Sector; Amount (Round)

1. TransTech Pharma, High Point; Pharmaceutical; $24 million (2nd)

Investors: MacAndrews & Forbes (lead), Cephaton and Novo Nordisk A/S

2. Targacept, Winston-Salem; Biotech; $14 million (2nd)

Investors: Nomura International Healthcare Private Equity Group (lead), Bison Capital, Cogene Biotech Ventures, JAFCO, Oxford Bioscience Partners and Rock Castle Ventures

3. TranS1, Wilmington; Medical devices; $12 million (2nd)

Investors: Advanced Technology Ventures (lead), Cutlass Capital, Delphi Ventures and Sapient Capital

4. Arsenal Digital Solutions, Cary; IT services; $10.5 million (4th)

Investors: Covestco, Southeast Interactive Technology Funds and Southern Cross Capital

5. Ephinay, Charlotte; IT services; $10 million (1st)

Investors: Chrys Capital

6. StemCo Biomedical, Durham; Biotech; $9.8 million (2nd)

Investors: Aurora Funds (co-lead), Intersouth Partners (co-lead), BD Ventures, Tall Oaks Capital and Trelys Venture Partners

7. OrthoNeuro, Charlotte; Medical; $8.5 million (NA)

Investors: New Enterprise Associates

8. Venetica, Charlotte; Software; $7 million (1st)

Investors: Charles River Ventures and General Catalyst Partners